The Chemoimmunotherapy Era in CLL is Over

被引：0

作者：

Thompson, Philip A. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷

关键词：

Chemotherapy; CLL; CHRONIC LYMPHOCYTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; OPEN-LABEL; PROGRESSION-FREE; FREE SURVIVAL; 17P DELETION; RITUXIMAB; CYCLOPHOSPHAMIDE; FLUDARABINE; VENETOCLAX;

D O I：

10.1016/j.clml.2018.06.077

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SA-S29-CLL

引用

页码：S116 / S119

页数：4

共 32 条

[11] First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial [J].

Eichhorst, Barbara ;

Fink, Anna-Maria ;

Bahlo, Jasmin ;

Busch, Raymonde ;

Kovacs, Gabor ;

Maurer, Christian ;

Lange, Elisabeth ;

Koeppler, Hubert ;

Kiehl, Michael ;

Soekler, Martin ;

Schlag, Rudolf ;

Vehling-Kaiser, Ursula ;

Koechling, Georg ;

Ploeger, Christoph ;

Gregor, Michael ;

Plesner, Torben ;

Trneny, Marek ;

Fischer, Kirsten ;

Doehner, Harmut ;

Kneba, Michael ;

Wendtner, Clemens-Martin ;

Klapper, Wolfram ;

Kreuzer, Karl-Anton ;

Stilgenbauer, Stephan ;

Boettcher, Sebastian ;

Hallek, Michael .

LANCET ONCOLOGY, 2016, 17 (07) :928-942

[12] Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial [J].

Fischer, Kirsten ;

Bahlo, Jasmin ;

Fink, Anna Maria ;

Goede, Valentin ;

Herling, Carmen Diana ;

Cramer, Paula ;

Langerbeins, Petra ;

von Tresckow, Julia ;

Engelke, Anja ;

Maurer, Christian ;

Kovacs, Gabor ;

Herling, Marco ;

Tausch, Eugen ;

Kreuzer, Karl-Anton ;

Eichhorst, Barbara ;

Boettcher, Sebastian ;

Seymour, John F. ;

Ghia, Paolo ;

Marlton, Paula ;

Kneba, Michael ;

Wendtner, Clemens-Martin ;

Doehner, Hartmut ;

Stilgenbauer, Stephan ;

Hallek, Michael .

BLOOD, 2016, 127 (02) :208-215

[13] Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia [J].

Furman, Richard R. ;

Sharman, Jeff P. ;

Coutre, Steven E. ;

Cheson, Bruce D. ;

Pagel, John M. ;

Hillmen, Peter ;

Barrientos, Jacqueline C. ;

Zelenetz, Andrew D. ;

Kipps, Thomas J. ;

Flinn, Ian ;

Ghia, Paolo ;

Eradat, Herbert ;

Ervin, Thomas ;

Lamanna, Nicole ;

Coiffier, Bertrand ;

Pettitt, Andrew R. ;

Ma, Shuo ;

Stilgenbauer, Stephan ;

Cramer, Paula ;

Aiello, Maria ;

Johnson, Dave M. ;

Miller, Langdon L. ;

Li, Daniel ;

Jahn, Thomas M. ;

Dansey, Roger D. ;

Hallek, Michael ;

O'Brien, Susan M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (11) :997-1007

[14] Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions [J].

Goede, Valentin ;

Fischer, Kirsten ;

Busch, Raymonde ;

Engelke, Anja ;

Eichhorst, Barbara ;

Wendtner, Clemens M. ;

Chagorova, Tatiana ;

de la Serna, Javier ;

Dilhuydy, Marie-Sarah ;

Illmer, Thomas ;

Opat, Stephen ;

Owen, Carolyn J. ;

Samoylova, Olga ;

Kreuzer, Karl-Anton ;

Stilgenbauer, Stephan ;

Doehner, Hartmut ;

Langerak, Anton W. ;

Ritgen, Matthias ;

Kneba, Michael ;

Asikanius, Elina ;

Humphrey, Kathryn ;

Wenger, Michael ;

Hallek, Michael .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (12) :1101-1110

[15] Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial [J].

Hallek, M. ;

Fischer, K. ;

Fingerle-Rowson, G. ;

Fink, A. M. ;

Busch, R. ;

Mayer, J. ;

Hensel, M. ;

Hopfinger, G. ;

Hess, G. ;

von Gruenhagen, U. ;

Bergmann, M. ;

Catalano, J. ;

Zinzani, P. L. ;

Caligaris-Cappio, F. ;

Seymour, J. F. ;

Berrebi, A. ;

Jaeger, U. ;

Cazin, B. ;

Trneny, M. ;

Westermann, A. ;

Wendtner, C. M. ;

Eichhorst, B. F. ;

Staib, P. ;

Buehler, A. ;

Winkler, D. ;

Zenz, T. ;

Boettcher, S. ;

Ritgen, M. ;

Mendila, M. ;

Kneba, M. ;

Doehner, H. ;

Stilgenbauer, S. .

LANCET, 2010, 376 (9747) :1164-1174

[16] Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study [J].

O'Brien, Susan ;

Jones, Jeffrey A. ;

Coutre, Steven E. ;

Mato, Anthony R. ;

Hillmen, Peter ;

Tam, Constantine ;

Osterborg, Anders ;

Siddiqi, Tanya ;

Thirman, Michael J. ;

Furman, Richard R. ;

Ilhan, Osman ;

Keating, Michael J. ;

Call, Timothy G. ;

Brown, Jennifer R. ;

Stevens-Brogan, Michelle ;

Li, Yunfeng ;

Clow, Fong ;

James, Danelle F. ;

Chu, Alvina D. ;

Hallek, Michael ;

Stilgenbauer, Stephan .

LANCET ONCOLOGY, 2016, 17 (10) :1409-1418

[17] Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia [J].

Robak, Tadeusz ;

Dmoszynska, Anna ;

Solal-Celigny, Philippe ;

Warzocha, Krzysztof ;

Loscertales, Javier ;

Catalano, John ;

Afanasiev, Boris V. ;

Larratt, Loree ;

Geisler, Christian H. ;

Montillo, Marco ;

Zyuzgin, Ilya ;

Ganly, Peter S. ;

Dartigeas, Caroline ;

Rosta, Andras ;

Maurer, Joerg ;

Mendila, Myriam ;

Saville, M. Wayne ;

Valente, Nancy ;

Wenger, Michael K. ;

Moiseev, Sergey I. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) :1756-1765

[18] Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia [J].

Roberts, Andrew W. ;

Davids, Matthew S. ;

Pagel, John M. ;

Kahl, Brad S. ;

Puvvada, Soham D. ;

Gerecitano, John F. ;

Kipps, Thomas J. ;

Anderson, Mary Ann ;

Brown, Jennifer R. ;

Gressick, Lori ;

Wong, Shekman ;

Dunbar, Martin ;

Zhu, Ming ;

Desai, Monali B. ;

Cerri, Elisa ;

Enschede, Sari Heitner ;

Humerickhouse, Rod A. ;

Wierda, William G. ;

Seymour, John F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (04) :311-322

[19]

ROGERS KA, 2017, BLOOD S1, V130

[20]

Rossi D, 2015, BLOOD

← 1 2 3 4 →